These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 36709118)
21. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx]. Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466 [TBL] [Abstract][Full Text] [Related]
22. Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire. Anderson S; Isaac A; Jeffery CC; Robinson JL; Isaac DM; Korownyk C; Biron VL; Seikaly H J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):61. PubMed ID: 29073940 [TBL] [Abstract][Full Text] [Related]
23. Five-year relative survival for human papillomavirus-associated cancer sites. Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738 [TBL] [Abstract][Full Text] [Related]
24. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis. Gilbert DC; Wakeham K; Langley RE; Vale CL Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States. Eytan DF; Blackford AL; Eisele DW; Fakhry C Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival. Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618 [TBL] [Abstract][Full Text] [Related]
27. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy. Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574 [TBL] [Abstract][Full Text] [Related]
28. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Smith EM; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP Cancer Causes Control; 2010 Sep; 21(9):1369-78. PubMed ID: 20401530 [TBL] [Abstract][Full Text] [Related]
29. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009. Forte T; Niu J; Lockwood GA; Bryant HE Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355 [TBL] [Abstract][Full Text] [Related]
30. Human Papillomavirus-Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review. Okerosi S; Mokoh LW; Rubagumya F; Niyibizi BA; Nkya A; Van Loon K; Buckle G; Bent S; Ha P; Fagan JJ; Ng D; Aswani J; Xu MJ JCO Glob Oncol; 2023 Jan; 9():e2200259. PubMed ID: 36730877 [TBL] [Abstract][Full Text] [Related]
31. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis. Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421 [TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus infection and non-oropharyngeal head and neck cancers: an umbrella review of meta-analysis. Petrelli F; Cin ED; Ghidini A; Carioli D; Falasca V; De Stefani A; Moleri G; Ardito R; Luciani A; Nardone M; Capriotti V Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):3921-3930. PubMed ID: 37212863 [TBL] [Abstract][Full Text] [Related]
33. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Gooi Z; Chan JY; Fakhry C Laryngoscope; 2016 Apr; 126(4):894-900. PubMed ID: 26845348 [TBL] [Abstract][Full Text] [Related]
34. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. Nelson RA; Lai LL Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917 [TBL] [Abstract][Full Text] [Related]
35. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Guo T; Eisele DW; Fakhry C Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637 [TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus infection by anatomical site among Greek men and women: a systematic review. Tsikis S; Hoefer L; Charnot-Katsikas A; Schneider JA Eur J Cancer Prev; 2016 Nov; 25(6):558-71. PubMed ID: 26628088 [TBL] [Abstract][Full Text] [Related]
37. HPV vaccination for prevention of head and neck cancer among men. El Hussein MT; Dhaliwal S Nurse Pract; 2023 Oct; 48(10):25-32. PubMed ID: 37751612 [TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. Gillison ML; Chaturvedi AK; Anderson WF; Fakhry C J Clin Oncol; 2015 Oct; 33(29):3235-42. PubMed ID: 26351338 [TBL] [Abstract][Full Text] [Related]
39. CE: Human Papillomavirus-Related Oropharyngeal Cancer: A Review of Nursing Considerations. McKiernan J; Thom B Am J Nurs; 2016 Aug; 116(8):34-43. PubMed ID: 27428508 [TBL] [Abstract][Full Text] [Related]
40. Epidemiology of HPV Related Malignancies. Scott-Wittenborn N; Fakhry C Semin Radiat Oncol; 2021 Oct; 31(4):286-296. PubMed ID: 34455984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]